Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other financing activities (2020 - 2024)

Fennec Pharmaceuticals' Other financing activities history spans 7 years, with the latest figure at $1.7 million for Q1 2024.

  • For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2024, changed N/A, and an annual FY2024 reading of $1.7 million, up 57900.0% over the prior year.
  • Other financing activities for Q1 2024 was $1.7 million at Fennec Pharmaceuticals, up from $224000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.7 million in Q1 2024, with the low at $23000.0 in Q2 2020.
  • Average Other financing activities over 4 years is $429200.0, with a median of $117000.0 recorded in 2020.
  • Biggest YoY gain for Other financing activities was 82.61% in 2021; the steepest drop was 82.61% in 2021.
  • Tracing FENC's Other financing activities over 4 years: stood at $117000.0 in 2020, then plummeted by 64.1% to $42000.0 in 2021, then surged by 433.33% to $224000.0 in 2022, then soared by 676.79% to $1.7 million in 2024.
  • Per Business Quant, the three most recent readings for FENC's Other financing activities are $1.7 million (Q1 2024), $224000.0 (Q4 2022), and $42000.0 (Q2 2021).